170 related articles for article (PubMed ID: 30320370)
21. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
[TBL] [Abstract][Full Text] [Related]
23. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
Zhao J; Nie Y; Wang H; Lin Y
Gene; 2016 Feb; 576(2 Pt 2):828-33. PubMed ID: 26589846
[TBL] [Abstract][Full Text] [Related]
24. miR‑195‑5p regulates multi‑drug resistance of gastric cancer cells via targeting ZNF139.
Nie H; Mu J; Wang J; Li Y
Oncol Rep; 2018 Sep; 40(3):1370-1378. PubMed ID: 29956811
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
Zhang Y; Lu Q; Cai X
FEBS Lett; 2013 Sep; 587(18):3069-75. PubMed ID: 23932924
[TBL] [Abstract][Full Text] [Related]
26. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
27. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer.
Chen S; Wu J; Jiao K; Wu Q; Ma J; Chen D; Kang J; Zhao G; Shi Y; Fan D; Zhao G
Cell Death Dis; 2018 Oct; 9(11):1070. PubMed ID: 30341283
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.
Zhang XY; Mu JH; Liu LY; Zhang HZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4071-4078. PubMed ID: 29028094
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
33. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
Zhu F; Wu Q; Ni Z; Lei C; Li T; Shi Y
Int J Mol Med; 2018 Jul; 42(1):228-236. PubMed ID: 29568890
[TBL] [Abstract][Full Text] [Related]
34. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
Wen L; Cheng F; Zhou Y; Yin C
Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
[TBL] [Abstract][Full Text] [Related]
35. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
[TBL] [Abstract][Full Text] [Related]
37. miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
Zhang X; Tang J; Zhi X; Xie K; Wang W; Li Z; Zhu Y; Yang L; Xu H; Xu Z
Oncotarget; 2015 Jan; 6(3):1605-17. PubMed ID: 25596740
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
[TBL] [Abstract][Full Text] [Related]
39. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
40. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
